Prothena (PRTA) Analyst & Key Data

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts7

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$8.93

Median Target+186.34%

$25.57

Potential upside vs current price

DCF Value-57.71%

$3.78

Potential downside vs current price

Current Stock Price

$8.93

Median Target+186.34%

$25.57

Potential upside vs current price

DCF Value-57.71%

$3.78

Potential downside vs current price

Analyst Consensus

Analyst recommendation mix is not available yet.

Total Analysts7

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$8.93

Median Target+186.34%

$25.57

Potential upside vs current price

DCF Value-57.71%

$3.78

Potential downside vs current price

Current Stock Price

$8.93

Median Target+186.34%

$25.57

Potential upside vs current price

DCF Value-57.71%

$3.78

Potential downside vs current price

Prothena Corporation plc